Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Recurrence 2 Breast Neoplasms 2 Stage IIIb and IV Non Small Cell Lung Cancer 1 Solid Tumor, Adult 1 Rare Diseases 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Neoplastic Syndromes, Hereditary 1 Neoplasm, Residual 1 Multiple Myeloma 1 Mouth Neoplasms 1 Microsatellite Instability 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Medullary 1 COVID-19 1 Biliary Tract Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

Everolimus 3 Capecitabine 3 lutetium Lu 177 dotatate 2 lenvatinib 2 cabozantinib 2 Thyroidectomy 2 Temozolomide 2 Sorafenib 2 Magnetic Resonance Spectroscopy 2 High-Energy Shock Waves 2 veliparib 1 vatalanib 1 vandetanib 1 temsirolimus 1 selpercatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 ponatinib 1 pentetreotide 1 pasireotide 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 fludarabine 1 cemiplimab 1 Vinorelbine 1 Thalidomide 1 Surgical Procedures, Operative 1 Sunitinib 1 Specimen Handling 1 Sirolimus 1 Semaxinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Medullary × High-Throughput Nucleotide Sequencing × Clear all

NCT04970134 2024-09-19

MOLTHY

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Active not recruiting

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡